Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3.70%22.22B | 3.10%15.66B | 0.92%8.14B | 5.87%31.37B | -23.86%21.43B | -23.54%15.19B | -18.25%8.07B | -25.67%29.63B | -6.85%28.14B | -8.32%19.86B |
| Operating income | 3.70%22.22B | 3.10%15.66B | 0.92%8.14B | 5.87%31.37B | -23.86%21.43B | -23.54%15.19B | -18.25%8.07B | -25.67%29.63B | -6.85%28.14B | -8.32%19.86B |
| Cost of sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 64.39%-1.47B |
| Operating expenses | 64.39%-1.47B | |||||||||
| Gross profit | 4.86%18.39B | |||||||||
| Administrative expenses | ---- | -0.95%-339.32M | ---- | -13.79%-810.18M | ---- | -1.39%-336.12M | ---- | 7.00%-712.02M | ---- | -0.30%-331.5M |
| Employee expense | ---- | -4.13%-2.13B | ---- | -12.81%-3.75B | ---- | 6.38%-2.04B | ---- | 7.16%-3.32B | ---- | -18.18%-2.18B |
| Depreciation and amortization | ---- | -11.82%-6.22B | ---- | -8.84%-11.56B | ---- | -5.09%-5.56B | ---- | -3.51%-10.62B | ---- | -6.52%-5.29B |
| Impairment and provision | ---- | -81.84%4.82M | ---- | 50.45%-1.1B | ---- | 521.50%26.57M | ---- | -28,790.40%-2.23B | ---- | -191.84%-6.3M |
| -Other impairment is provision | ---- | -81.84%4.82M | ---- | 50.45%-1.1B | ---- | 521.50%26.57M | ---- | -28,790.40%-2.23B | ---- | -191.84%-6.3M |
| Special items of operating profit | -10.87%-13.13B | -157.83%-246.53M | -14.29%-4.51B | -30.42%-1.53B | 30.19%-11.84B | 95.11%-95.62M | 31.48%-3.94B | 83.40%-1.18B | 12.69%-16.97B | 11.26%-1.96B |
| Operating profit | -5.16%9.09B | -6.22%6.73B | -11.87%3.63B | 9.02%12.61B | -14.25%9.58B | -16.78%7.18B | 0.25%4.12B | -2.79%11.57B | 3.67%11.18B | 5.21%8.62B |
| Financing income | ---- | -43.58%70.57M | ---- | -39.19%146.38M | ---- | -41.84%125.07M | ---- | -21.55%240.72M | ---- | 0.18%215.04M |
| Financing cost | -2.10%-2.55B | -0.52%-1.76B | 6.06%-825.26M | 3.53%-3.57B | 1.05%-2.49B | 1.63%-1.75B | -10.05%-878.53M | 9.94%-3.7B | 14.10%-2.52B | 10.41%-1.78B |
| Share of profits of associates | -23.71%93.69M | 36.81%112.23M | 745.37%47.81M | 3,569.05%165.14M | 664.41%122.8M | 253.89%82.03M | 108.13%5.66M | 101.07%4.5M | 109.60%16.07M | 51.90%-53.3M |
| Earning before tax | -7.99%6.64B | -8.52%5.15B | -12.12%2.86B | 15.28%9.36B | -16.83%7.21B | -19.60%5.63B | 0.16%3.25B | 5.65%8.12B | 12.93%8.67B | 10.97%7B |
| Tax | -0.03%-1.21B | -2.69%-974.97M | -3.29%-517.54M | -18.86%-1.67B | 8.65%-1.21B | 18.47%-949.44M | 3.99%-501.06M | 9.52%-1.41B | 2.65%-1.32B | 0.38%-1.16B |
| After-tax profit from continuing operations | -9.60%5.43B | -10.80%4.17B | -14.93%2.34B | 14.53%7.69B | -18.30%6B | -19.83%4.68B | 0.96%2.75B | 9.50%6.71B | 16.27%7.35B | 13.56%5.84B |
| After-tax profit from non-continuing business | ---- | ---- | ---- | 169.00%682.42M | --511.18M | --184.16M | --102.86M | --253.69M | ---- | ---- |
| Earning after tax | -16.69%5.43B | -14.18%4.17B | -17.99%2.34B | 20.16%8.37B | -11.35%6.52B | -16.67%4.86B | 4.74%2.85B | 13.64%6.96B | 16.27%7.35B | 13.56%5.84B |
| Minority profit | 7.08%815.3M | -13.19%654.99M | 11.86%362.52M | 251.10%1.94B | -20.27%761.37M | 6.25%754.55M | 6.27%324.09M | -44.50%553.52M | -0.43%954.96M | -12.13%710.15M |
| Profit attributable to shareholders | -19.84%4.61B | -14.36%3.52B | -21.82%1.98B | 0.22%6.42B | -10.02%5.75B | -19.85%4.11B | 4.54%2.53B | 24.95%6.41B | 19.26%6.4B | 18.35%5.13B |
| Basic earnings per share | -13.62%0.421 | 2.22%0.763 | -18.78%0.4874 | 27.33%0.7464 | 18.78%0.6001 | |||||
| Diluted earnings per share | -13.62%0.421 | 2.22%0.763 | -18.78%0.4874 | 27.33%0.7464 | 18.78%0.6001 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG | -- | -- | -- | Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.